Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.

Shasha, Daniel

Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy. [electronic resource] - Cancer Sep 2003 - 1072-9 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0008-543X

10.1002/cncr.11616 doi


Aged
Anemia--drug therapy
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Combined Modality Therapy
Drug Administration Schedule
Epoetin Alfa
Erythropoietin--administration & dosage
Female
Hematinics--administration & dosage
Hemoglobins--analysis
Humans
Injections, Subcutaneous
Male
Middle Aged
Neoplasms--drug therapy
Quality of Life
Radiotherapy--adverse effects
Recombinant Proteins